
We use AI to design antibodies for intractable diseases
screenshot pendingNabla Bio is a biotechnology company focused on transforming drug development into a design discipline. Their mission is to reduce the reliance on trial-and-error methods in drug discovery, enabling the creation of better medicines that can reach patients more quickly and with increased reliability. The company emphasizes the importance of design in drug development, aiming to make the process more predictable and efficient.
The core of Nabla Bio's approach lies in its generative drug design platform, which integrates advanced artificial intelligence with large-scale, human-relevant testing.…